Probity Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.44M | Sell |
20,319
-503
| -2% | -$58.1K | 0.39% | 52 |
|
|
2025
Q4 | $2.19M | Buy |
20,822
+688
| +3% | +$64.6K | 0.35% | 57 |
|
|
2025
Q3 | $1.69M | Buy |
20,134
+1,219
| +6% | +$100K | 0.27% | 67 |
|
|
2025
Q2 | $1.5M | Buy |
18,915
+1,168
| +7% | +$92.8K | 0.26% | 68 |
|
|
2025
Q1 | $1.59M | Buy |
17,747
+830
| +5% | +$77.5K | 0.31% | 59 |
|
|
2024
Q4 | $1.68M | Buy |
16,917
+683
| +4% | +$70.4K | 0.32% | 58 |
|
|
2024
Q3 | $1.84M | Buy |
16,234
+226
| +1% | +$26.9K | 0.35% | 59 |
|
|
2024
Q2 | $1.98M | Sell |
16,008
-712
| -4% | -$91.7K | 0.41% | 55 |
|
|
2024
Q1 | $2.21M | Sell |
16,720
-252
| -1% | -$31.1K | 0.46% | 46 |
|
|
2023
Q4 | $1.85M | Sell |
16,972
-180
| -1% | -$18.7K | 0.4% | 50 |
|
|
2023
Q3 | $1.77M | Sell |
17,152
-71
| -0.4% | -$7.65K | 0.41% | 41 |
|
|
2023
Q2 | $1.99M | Buy |
+17,223
| New | +$1.96M | 0.43% | 38 |
|
|
2022
Q4 | $2.02M | Sell |
18,197
-489
| -3% | -$50K | 0.46% | 37 |
|
|
2022
Q3 | $1.61M | Sell |
18,686
-1,330
| -7% | -$119K | 0.4% | 41 |
|
|
2022
Q2 | $1.82M | Sell |
20,016
-290
| -1% | -$25.7K | 0.42% | 40 |
|
|
2022
Q1 | $1.67M | Sell |
20,306
-1,315
| -6% | -$104K | 0.34% | 54 |
|
|
2021
Q4 | $1.66M | Buy |
21,621
+263
| +1% | +$20.9K | 0.33% | 56 |
|
|
2021
Q3 | $1.6M | Buy |
21,358
+1,049
| +5% | +$79.8K | 0.33% | 59 |
|
|
2021
Q2 | $1.58M | Sell |
20,309
-1,000
| -5% | -$74.4K | 0.33% | 57 |
|
|
2021
Q1 | $1.57M | Buy |
+21,309
| New | +$1.57M | 0.35% | 55 |
|
|
2020
Q3 | $1.61M | Buy |
20,364
+23
| +0.1% | +$1.8K | 0.46% | 48 |
|
|
2020
Q2 | $1.5M | Buy |
20,341
+605
| +3% | +$45.5K | 0.47% | 47 |
|
|
2020
Q1 | $1.45M | Sell |
19,736
-215
| -1% | -$16.9K | 0.53% | 39 |
|
|
2019
Q4 | $1.73M | Sell |
19,951
-336
| -2% | -$27.6K | 0.52% | 43 |
|
|
2019
Q3 | $1.63M | Buy |
20,287
+3
| +0% | +$240 | 0.53% | 44 |
|
|
2019
Q2 | $1.62M | Sell |
20,284
-679
| -3% | -$52K | 0.54% | 43 |
|
|
2019
Q1 | $1.66M | Sell |
20,963
-58
| -0.3% | -$4.34K | 0.57% | 43 |
|
|
2018
Q4 | $1.53M | Sell |
21,021
-228
| -1% | -$16.1K | 0.57% | 45 |
|
|
2018
Q3 | $1.44M | Sell |
21,249
-847
| -4% | -$54K | 0.47% | 54 |
|
|
2018
Q2 | $1.28M | Sell |
22,096
-166
| -0.7% | -$9.37K | 0.45% | 53 |
|
|
2018
Q1 | $1.16M | Buy |
22,262
+1,361
| +7% | +$73.5K | 0.4% | 58 |
|
|
2017
Q4 | $1.12M | Sell |
20,901
-1,947
| -9% | -$108K | 0.39% | 51 |
|
|
2017
Q3 | $1.4M | Buy |
22,848
+641
| +3% | +$38.9K | 0.52% | 40 |
|
|
2017
Q2 | $1.36M | Buy |
22,207
+1,202
| +6% | +$73.2K | 0.51% | 40 |
|
|
2017
Q1 | $1.27M | Buy |
21,005
+382
| +2% | +$23.2K | 0.49% | 41 |
|
|
2016
Q4 | $1.16M | Buy |
20,623
+914
| +5% | +$53.5K | 0.49% | 43 |
|
|
2016
Q3 | $1.17M | Sell |
19,709
-273
| -1% | -$16K | 0.51% | 43 |
|
|
2016
Q2 | $1.1M | Buy |
+19,982
| New | +$1.06M | 0.49% | 48 |
|
Other funds holding MRK
VCM
VPM
Probity Advisors's MRK Position: Q1 2026 in Review
Probity Advisors reduced its Merck (MRK) stake by 2.4% in Q1 2026, selling an estimated $58.1K and leaving 20,319 shares worth $2.44M. The position accounts for 0.39% of the portfolio, ranked #52.
Probity Advisors first reported a position in MRK in Q2 2016 and has held it in 38 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Probity Advisors held 20,319 shares of Merck worth $2.44M as of Q1 2026.
- Probity Advisors sold 503 Merck shares in Q1 2026, an estimated $58.1K.
- Merck made up 0.39% of Probity Advisors's portfolio in Q1 2026, its #52 holding.
- Probity Advisors first reported a position in Merck in Q2 2016 and has held it in 38 quarters since.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Probity Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.